| Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. | |
| | |
MedLine Citation:
|
PMID: 9088884 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Previous reports have stressed the implication of Personality Disorders as predictors of a poorer treatment outcome in Obsessive-Compulsive Disorder (OCD). The aim of this study was to see whether or not Obsessive-Compulsive Personality Disorder in Obsessive-Compulsive Disorder may be predictive for a poorer outcome to antiobsessive pro-serotonergic pharmacological treatment. For this purpose, 30 OCD patients were divided into two groups according to the presence or absence of Obsessive-Compulsive Personality Disorder. Ten-week standardized treatments with oral SRI drugs were given to look for different outcomes between the two groups in Obsessive-Compulsive symptom severity. At the end of the study we found that the presence of Obsessive-Compulsive Personality Disorder, along with the total number of Personality Disorders, did predict poorer response to pharmacological treatment in OCD. |
| | |
Authors:
|
P Cavedini; S Erzegovesi; P Ronchi; L Bellodi |
Related Documents
:
|
8486594 - Postpartum obsessive compulsive disorder: a case series. 2662154 - Obsessive-compulsive disorder. how primary care physicians can help. 9826244 - Clinical features and psychiatric comorbidity of subjects with pathological gambling be... 17135374 - The value of quantitative electroencephalography in clinical psychiatry: a report by th... 17717414 - The spectrum of dementia: frequency, causes and clinical profile. a national referral h... 23468104 - Evolution of mycobacterium tuberculosis. |
Publication Detail:
|
Type: Clinical Trial; Journal Article |
Journal Detail:
|
Title: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Volume: 7 ISSN: 0924-977X ISO Abbreviation: Eur Neuropsychopharmacol Publication Date: 1997 Feb |
Date Detail:
|
Created Date: 1997-07-23 Completed Date: 1997-07-23 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9111390 Medline TA: Eur Neuropsychopharmacol Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 45-9 Citation Subset: IM |
Affiliation:
|
Ospedale San Raffaele, Department of Neuropsychiatric Sciences, University of Milan School of Medicine, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antidepressive Agents, Second-Generation / administration & dosage, therapeutic use* Antidepressive Agents, Tricyclic / administration & dosage, therapeutic use* Clomipramine / administration & dosage, therapeutic use* Female Fluvoxamine / administration & dosage, therapeutic use* Humans Male Obsessive-Compulsive Disorder / drug therapy*, psychology* Predictive Value of Tests Psychiatric Status Rating Scales |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents, Second-Generation; 0/Antidepressive Agents, Tricyclic; 303-49-1/Clomipramine; 54739-18-3/Fluvoxamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia an...
Next Document: Risk factors for the development of neuroleptic induced akathisia.